On October 14, 2013, the U.S. Food and Drug Administration approved Otrexup (methotrexate). Certainly methotrexate is not a new drug, but Otrexup is a once-weekly, single dose, disposable auto-injector which has been designed for self-administration.
According to its maker Antares Pharma, Inc., Otrexup is indicated for adults with severe active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis, and severe psoriasis that is not responsive to other treatments. Methotrexate has long been available as oral tablets and in an injectable form which required patients to use a syringe and vial of methotrexate solution. With the easy-to-use auto-injector, Otrexup will provide another option for patients who prefer to self-inject methotrexate but may have been unable to do so because of hand arthritis, fear of needles, or lack of confidence. The availability of Otrexup is planned for early 2014.
- Methotrexate - 10 Things You Should Know
- Methotrexate Quiz
- Is Methotrexate Injection Better Than Oral Methotrexate?